Brief: Apontis Pharma And Develco Pharma Enter Development Partnership
05/05/2022 06:41
May 5 (Reuters) - APONTIS PHARMA AG APPHG.DE :
* APONTIS PHARMA AND DEVELCO PHARMA ENTER DEVELOPMENT
PARTNERSHIP
FOR LAUNCH OF TWO SINGLE PILLS WITH PAN-EUROPEAN INTELLECTUAL
PROPERTY RIGHTS
* FURTHER EXPANSION OF MID-TERM SINGLE PILL PORTFOLIO FOR
TREATMENT OF HYPERTENSION WITH TWO NEW SINGLE PILLS
Source text for Eikon: ID:nEQ6sC1yYa
Further company coverage: APPHG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Apontis Pharma AG
See all newsBrief: Bruno Wohschlegel To Leave Apontis Pharma As CEO End Of August
Brief: APONTIS PHARMA Q1 EBITDA EUR 1.3 Million
Brief: Apontis Pharma Says Zentiva AG Submits Formal Request To Carry Out A Merger
Brief: Zentiva Says Amendeds Offer To Acquire Each Outstanding Share Of Apontis Pharma In Cash By Waiving Condition Of A Minimum Acceptance
Brief: Apontis Pharma: Zentiva To Launch Voluntary Public Purchase Offer At EUR 10.00 Per Share